Premier Gross Margin 2012-2024 | PINC
Current and historical gross margin for Premier (PINC) over the last 10 years. The current gross profit margin for Premier as of September 30, 2024 is %.
| Premier Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $1.33B | $0.86B | 65.08% |
| 2024-06-30 | $1.35B | $0.89B | 65.92% |
| 2024-03-31 | $1.29B | $0.88B | 68.22% |
| 2023-12-31 | $1.27B | $0.88B | 69.27% |
| 2023-09-30 | $1.29B | $0.90B | 69.64% |
| 2023-06-30 | $1.34B | $0.90B | 67.07% |
| 2023-03-31 | $1.34B | $0.89B | 66.42% |
| 2022-12-31 | $1.36B | $0.88B | 64.64% |
| 2022-09-30 | $1.38B | $0.88B | 63.31% |
| 2022-06-30 | $1.43B | $0.89B | 61.76% |
| 2022-03-31 | $1.57B | $0.88B | 55.97% |
| 2021-12-31 | $1.70B | $0.88B | 51.95% |
| 2021-09-30 | $1.74B | $0.86B | 49.14% |
| 2021-06-30 | $1.72B | $0.84B | 48.66% |
| 2021-03-31 | $1.58B | $0.82B | 51.93% |
| 2020-12-31 | $1.45B | $0.84B | 58.15% |
| 2020-09-30 | $1.35B | $0.85B | 63.20% |
| 2020-06-30 | $1.30B | $0.87B | 66.62% |
| 2020-03-31 | $1.27B | $0.88B | 69.13% |
| 2019-12-31 | $1.24B | $0.86B | 69.65% |
| 2019-09-30 | $1.23B | $0.86B | 70.42% |
| 2019-06-30 | $1.22B | $0.86B | 70.77% |
| 2019-03-31 | $0.86B | $0.86B | 99.53% |
| 2018-12-31 | $0.98B | $0.86B | 87.69% |
| 2018-09-30 | $1.09B | $0.85B | 78.55% |
| 2018-06-30 | $1.18B | $0.84B | 71.20% |
| 2018-03-31 | $1.24B | $0.83B | 66.83% |
| 2017-12-31 | $1.20B | $0.81B | 67.75% |
| 2017-09-30 | $1.15B | $0.78B | 68.30% |
| 2017-06-30 | $1.07B | $0.76B | 71.04% |
| 2017-03-31 | $1.35B | $0.74B | 54.55% |
| 2016-12-31 | $1.27B | $0.72B | 56.76% |
| 2016-09-30 | $1.21B | $0.72B | 59.67% |
| 2016-06-30 | $1.16B | $0.71B | 60.71% |
| 2016-03-31 | $1.13B | $0.69B | 60.67% |
| 2015-12-31 | $1.09B | $0.66B | 60.16% |
| 2015-09-30 | $1.05B | $0.63B | 60.34% |
| 2015-06-30 | $1.01B | $0.61B | 60.58% |
| 2015-03-31 | $0.98B | $0.60B | 61.74% |
| 2014-12-31 | $0.94B | $0.59B | 62.51% |
| 2014-09-30 | $0.90B | $0.57B | 63.18% |
| 2014-06-30 | $0.91B | $0.60B | 66.08% |
| 2014-03-31 | $0.92B | $0.63B | 68.70% |
| 2013-12-31 | $0.92B | $0.65B | 70.82% |
| 2013-09-30 | $0.91B | $0.66B | 72.37% |
| 2013-06-30 | $0.87B | $0.63B | 72.53% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.156B | $1.346B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $89.358B | 11.09 |
| Cencora (COR) | United States | $46.783B | 17.59 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| Natera (NTRA) | United States | $20.907B | 0.00 |
| ICON (ICLR) | Ireland | $16.343B | 14.56 |
| Avantor (AVTR) | United States | $15.048B | 22.56 |
| Revvity (RVTY) | United States | $14.408B | 25.03 |
| BioMerieux (BMXMF) | France | $13.788B | 0.00 |
| Viatris (VTRS) | United States | $13.488B | 4.15 |
| Solventum (SOLV) | United States | $12.699B | 0.00 |
| CochLear (CHEOY) | Australia | $12.341B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.485B | 29.54 |
| Doximity (DOCS) | United States | $10.029B | 59.03 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.551B | 0.00 |
| HealthEquity (HQY) | United States | $8.876B | 44.53 |
| Charles River Laboratories (CRL) | United States | $8.361B | 16.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.244B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $6.118B | 28.46 |
| Organon (OGN) | United States | $4.054B | 4.09 |
| Sotera Health (SHC) | United States | $3.676B | 19.67 |
| BrightSpring Health Services (BTSG) | United States | $3.230B | 68.70 |
| Alignment Healthcare (ALHC) | United States | $2.795B | 0.00 |
| Concentras Parent (CON) | United States | $2.691B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.566B | 29.26 |
| PACS (PACS) | United States | $2.106B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.013B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.909B | 0.00 |
| Progyny (PGNY) | United States | $1.788B | 36.21 |
| GoodRx Holdings (GDRX) | United States | $1.742B | 45.70 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.565B | 0.00 |
| Agilon Health (AGL) | United States | $1.273B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.189B | 11.63 |
| CareDx (CDNA) | United States | $1.150B | 0.00 |
| Embecta (EMBC) | United States | $1.086B | 7.59 |
| AMN Healthcare Services Inc (AMN) | United States | $0.986B | 6.67 |
| Establishment Labs Holdings (ESTA) | $0.968B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.624B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.484B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.429B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.426B | 11.15 |
| DocGo (DCGO) | United States | $0.426B | 16.04 |
| Enhabit (EHAB) | United States | $0.402B | 34.74 |
| MultiPlan (MPLN) | United States | $0.260B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.239B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.217B | 0.00 |
| Beauty Health (SKIN) | United States | $0.216B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Nutex Health (NUTX) | United States | $0.206B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.181B | 0.00 |
| Biodesix (BDSX) | United States | $0.167B | 0.00 |
| So-Young (SY) | China | $0.110B | 18.60 |
| ModivCare (MODV) | United States | $0.093B | 5.03 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 1.63 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| Oncology Institute (TOI) | United States | $0.042B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| KindlyMD (KDLY) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |